Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNNjVoSU9HTEVkeHMwTjA1am80UWh1NW1uRmlvX211dTQ5OEREOTJGdElSaFR3WWxUNmxLWG9MNXltemNTa3RxbS04cUxlNVFHOG5jWXdKTVFOTV9XZkpuV01aVEZMVmFVTm14WlJ1aVFsUmtkc183ZkhjUURsMlprbUp2M1RVZ2dBckFMVWdFLUIzcVNieG91Zk9WTFd5clJfTHZmVG1ta3pBVHE2SzhPdUhweTZ0cms?oc=5" target="_blank">Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMNovo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PM